Saturday, Oct 21, 2017
HomeNewsMappBio Announces Contracts with BARDA for ZMapp and Additional Filovirus Medical Countermeasures

MappBio Announces Contracts with BARDA for ZMapp and Additional Filovirus Medical Countermeasures

Mapp Biopharmaceutical, Inc., announced today that it has been awarded a Project BioShield contract (HHSO100201700017C) of approximately $46 million by The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to advance ZMappTM to licensure by the Food and Drug Administration (FDA). A [PR.com]Original Article

NO COMMENTS

LEAVE A COMMENT

X
})(jQuery)